GFAP levels increased in end-stage ALS rats along with the activation of inflammatory cells, such as macrophages, this suggested that inflammation may be a responsible factor for the increase of active glial cells in the skeletal muscle of SOD1G93A transgenic rats. The gene discussed is GFAP; the disease is amyotrophic lateral sclerosis.